AASLD EXPO: Liver biopsy

IF 18 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY
Elizabeth C. Verna,Douglas G. Adler,Matthew R. Kappus,Elizabeth B. Rand,Elliot B. Tapper,Don C. Rockey
{"title":"AASLD EXPO: Liver biopsy","authors":"Elizabeth C. Verna,Douglas G. Adler,Matthew R. Kappus,Elizabeth B. Rand,Elliot B. Tapper,Don C. Rockey","doi":"10.1097/hep.0000000000001828","DOIUrl":null,"url":null,"abstract":"Background: Liver biopsy is a foundational tool in hepatology, providing direct histologic assessment of hepatic parenchyma. Although noninvasive approaches have substantially reduced the need for biopsy in practice, it continues to play a critical role in diagnosis, staging, and therapeutic decision-making across a broad spectrum of liver disorders. Methods: This Expert Practice Opinion (EXPO) document was created by a writing group of subject matter experts appointed by the AASLD Practice Guidelines Committee. Writing group members performed a targeted literature review and created expert opinion statements that were unanimously agreed upon. Results: Histopathologic evaluation of the liver is utilized for 3 major indications: (1) to establish a diagnosis, (2) to stage the severity of inflammation and/or fibrosis, and (3) to enhance clinical management of liver disease. Liver biopsy can be performed using a percutaneous, transjugular, or endoscopic ultrasound approach. Percutaneous liver biopsy is used in most patients, though transjugular liver biopsy is often performed in those with ascites or coagulopathy and/or when hepatic venous pressure gradient measurement is desired. Endoscopic ultrasound–guided liver biopsy is particularly attractive when endoscopy to evaluate and treat varices or portal pressure gradient measurement is desired. The different biopsy techniques appear to have similar safety profiles and yield adequate tissue when performed by experts. Liver biopsy has limitations, including sampling variability, interobserver differences in interpretation, and procedural complications. Conclusions: Liver biopsy continues to play an essential role in contemporary hepatology practice. Recent advances include the introduction of endoscopic ultrasound liver biopsy. Evolving applications—including the potential for molecular profiling, use of digital pathology, and assessment of therapeutic response—underscore the continued relevance of tissue-based evaluation in precision hepatology.","PeriodicalId":177,"journal":{"name":"Hepatology","volume":"9 1","pages":""},"PeriodicalIF":18.0000,"publicationDate":"2026-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hepatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/hep.0000000000001828","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Liver biopsy is a foundational tool in hepatology, providing direct histologic assessment of hepatic parenchyma. Although noninvasive approaches have substantially reduced the need for biopsy in practice, it continues to play a critical role in diagnosis, staging, and therapeutic decision-making across a broad spectrum of liver disorders. Methods: This Expert Practice Opinion (EXPO) document was created by a writing group of subject matter experts appointed by the AASLD Practice Guidelines Committee. Writing group members performed a targeted literature review and created expert opinion statements that were unanimously agreed upon. Results: Histopathologic evaluation of the liver is utilized for 3 major indications: (1) to establish a diagnosis, (2) to stage the severity of inflammation and/or fibrosis, and (3) to enhance clinical management of liver disease. Liver biopsy can be performed using a percutaneous, transjugular, or endoscopic ultrasound approach. Percutaneous liver biopsy is used in most patients, though transjugular liver biopsy is often performed in those with ascites or coagulopathy and/or when hepatic venous pressure gradient measurement is desired. Endoscopic ultrasound–guided liver biopsy is particularly attractive when endoscopy to evaluate and treat varices or portal pressure gradient measurement is desired. The different biopsy techniques appear to have similar safety profiles and yield adequate tissue when performed by experts. Liver biopsy has limitations, including sampling variability, interobserver differences in interpretation, and procedural complications. Conclusions: Liver biopsy continues to play an essential role in contemporary hepatology practice. Recent advances include the introduction of endoscopic ultrasound liver biopsy. Evolving applications—including the potential for molecular profiling, use of digital pathology, and assessment of therapeutic response—underscore the continued relevance of tissue-based evaluation in precision hepatology.
AASLD EXPO:肝脏活检
背景:肝活检是肝病学的基础工具,提供肝实质的直接组织学评估。尽管无创方法在实践中大大减少了对活检的需求,但它仍然在广泛的肝脏疾病的诊断、分期和治疗决策中发挥着关键作用。方法:本专家实践意见(EXPO)文件由AASLD实践指南委员会任命的主题专家撰写小组创建。写作小组成员进行了有针对性的文献回顾,并创造了一致同意的专家意见陈述。结果:肝脏的组织病理学评估有3个主要适应症:(1)建立诊断,(2)对炎症和/或纤维化的严重程度进行分期,(3)加强肝脏疾病的临床管理。肝活检可以通过经皮、经颈或内窥镜超声方法进行。大多数患者采用经皮肝活检,但经颈静脉肝活检常用于腹水或凝血功能障碍患者和/或需要测量肝静脉压力梯度的患者。内镜下超声引导下的肝活检在内镜下评估和治疗静脉曲张或门静脉压力梯度测量时特别有吸引力。不同的活检技术似乎具有相似的安全性,并且在专家执行时产生足够的组织。肝活检有局限性,包括采样可变性、观察者之间解释的差异和程序并发症。结论:肝活检在当代肝病学实践中继续发挥重要作用。最近的进展包括引入内窥镜超声肝活检。不断发展的应用——包括分子分析的潜力、数字病理学的使用和治疗反应的评估——强调了基于组织的评估在精确肝病学中的持续相关性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Hepatology
Hepatology 医学-胃肠肝病学
CiteScore
27.50
自引率
3.70%
发文量
609
审稿时长
1 months
期刊介绍: HEPATOLOGY is recognized as the leading publication in the field of liver disease. It features original, peer-reviewed articles covering various aspects of liver structure, function, and disease. The journal's distinguished Editorial Board carefully selects the best articles each month, focusing on topics including immunology, chronic hepatitis, viral hepatitis, cirrhosis, genetic and metabolic liver diseases, liver cancer, and drug metabolism.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书